Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $122.0200 (-0.43%) ($122.0200 - $122.0200) on Fri. Jul. 23, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.58% (three month average) | RSI | 34 | Latest Price | $122.0200(-0.43%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 1.4% a day on average for past five trading days. | Weekly Trend | LGND declines -2.6% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(58%) IWO(57%) IWM(55%) IWC(53%) IWN(50%) | Factors Impacting LGND price | LGND will decline at least -1.29% in a week (0% probabilities). VIXM(-26%) VXX(-16%) UUP(-16%) IGOV(-6%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.29% (StdDev 2.58%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
Resistance Level | $126.3 | 5 Day Moving Average | $122.46(-0.36%) | 10 Day Moving Average | $120.75(1.05%) | 20 Day Moving Average | $126.3(-3.39%) | To recent high | -19.5% | To recent low | 8% | Market Cap | $1.961b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |